Preterm Birth and PROM Testing Market Rising with 1.31 bn by 2020 to 2027

As per the research held by Acumen Research and Consulting, “the global Preterm Birth and PROM Testing market anticipated to exceed 1.31 billion by 2027, along with the projected CAGR of 1.74% from 2020 to 2027”.

The global Preterm Birth and PROM Testing market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1263

The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.

The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.

Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.

In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.

Market participants

Qiagen, Hologic, Cooper Surgical, Abbott Laboratories, Medixbiochemica, Sera Prognostics, Biosynex, and IQ Products

Market segmentation

Market Segmentation, By Test Type:

• Preterm Birth Tests
• Pelvic Exam
• Ultrasound
• Uterine Monitoring
• Biomarkers
• PROM Tests
• Nitrazine Test
• Ferning Test
• Pooling
• Ultrasound
• Fetal Fibronectin Test
• Biomarker Tests
• Others
• Market Segmentation, By End-user:
• Hospitals
• Diagnostic Laboratories
• Others

Market Segmentation, By Region:

• North America
• Europe
• Asia Pacific
• Central & South America
• Middle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Preterm Birth and PROM Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Preterm Birth and PROM Testing Market By Test Type
1.2.2.1. Global Preterm Birth and PROM Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.2.2. Global Preterm Birth and PROM Testing Market Revenue Share By Test Type in 2017
1.2.2.3. Preterm Birth Tests
1.2.2.3.1. Pelvic Exam
1.2.2.3.2. Ultrasound
1.2.2.3.3. Uterine Monitoring
1.2.2.3.4. Biomarkers
1.2.2.4. PROM Tests
1.2.2.4.1. Nitrazine Test
1.2.2.4.2. Ferning Test
1.2.2.4.3. Pooling
1.2.2.4.4. Ultrasound
1.2.2.4.5. Fetal Fibronectin Test
1.2.2.4.6. Biomarker Tests
1.2.2.4.7. Others
1.2.2.4.8. Market Segmentation, By End-user:
1.2.2.4.9. Hospitals
1.2.2.4.10. Diagnostic Laboratories
1.2.2.5. Others
1.2.3. Preterm Birth and PROM Testing Market by Geography
1.2.3.1. Global Preterm Birth and PROM Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
CHAPTER 4. PRETERM BIRTH AND PROM TESTING MARKET BY TEST TYPE
4.1. Global Preterm Birth and PROM Testing Revenue By Test Type
4.2. Preterm Birth Tests
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.2.3. Pelvic Exam
4.2.4. Ultrasound
4.2.5. Uterine Monitoring
4.2.6. Biomarkers
4.3. PROM Tests
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3.3. Nitrazine Test
4.3.4. Ferning Test
4.3.5. Pooling
4.3.6. Ultrasound
4.3.7. Fetal Fibronectin Test
4.3.8. Biomarker Tests
4.3.9. Others
4.3.10. Market Segmentation, By End-user:
4.3.11. Hospitals
4.3.12. Diagnostic Laboratories
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. NORTH AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
5.1. North America Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2. North America Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Preterm Birth and PROM Testing Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 6. EUROPE PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
6.1. Europe Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. Europe Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 7. ASIA-PACIFIC PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
7.1. Asia-Pacific Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Asia-Pacific Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 8. LATIN AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
8.1. Latin America Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Latin America Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 9. MIDDLE EAST PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
9.1. Middle East Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Middle East Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 10. AFRICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY
10.1. Africa Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Africa Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Qiagen
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Hologic
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Cooper Surgical
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Medixbiochemica
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Sera Prognostics
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Biosynex
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. IQ Products
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Others
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1263

Contact us:

Sheetal k

Email: [email protected]

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com